You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RAS mutation

Showing 1 - 25 of 3,174
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Trial (PD-1, SCRT, Bevacizumab)

Not yet recruiting
  • Rectal Cancer
  • (no location specified)
Dec 6, 2022

Advanced Solid Tumor, RAS Mutation, RAF Mutation Trial in Houston, Irving (ABM-168)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Houston, Texas
  • +1 more
Apr 14, 2023

RAS Mutation, NRAS Gene Mutation, Melanoma Trial in Phoenix, Newnan, Zion (OKI-179 + binimetinib)

Recruiting
  • RAS Mutation
  • +2 more
  • OKI-179 + binimetinib
  • Phoenix, Arizona
  • +4 more
Sep 22, 2022

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

RAS Mutation, Neurofibromatosis 1, Noonan Syndrome Trial in Cincinnati

Recruiting
  • RAS Mutation
  • +13 more
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Feb 24, 2022

    Metastatic Colorectal Cancer Trial in France (Nexavar (Sorafenib) and irinotecan (Campto))

    Completed
    • Metastatic Colorectal Cancer
    • Nexavar (Sorafenib) and irinotecan (Campto)
    • Lille, France
    • +4 more
    Jun 17, 2021

    Colorectal Cancer, Metastatic Colorectal Cancer, RAS Mutation Trial in Italy (Bevacizumab, Cetuximab, 5-FU)

    Recruiting
    • Colorectal Cancer
    • +2 more
    • Coppito, L'Aquila, Italy
    • +3 more
    Sep 10, 2021

    Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation Trial in Villejuif (Trametinib,

    Active, not recruiting
    • Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Sep 27, 2021

    RAS Mutation Status in Liquid Biopsies in RAS Wild-type.PERSEIDA

    Completed
    • RAS Wild Type mCRC
      • Almeria, Andalucía, Spain
      • +23 more
      Jun 17, 2021

      Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)

      Not yet recruiting
      • Hematologic Malignancy
      • +21 more
      • (no location specified)
      Feb 9, 2023

      Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +5 more
      • RSC-1255 Dose Escalation
      • RSC-1255 Dose Expansion
      • Los Angeles, California
      • +5 more
      Oct 24, 2022

      Metastatic Colorectal Cancer, RAS Mutation Trial in Hangzhou (sintilimab injection, Control Test)

      Recruiting
      • Metastatic Colorectal Cancer
      • RAS Mutation
      • sintilimab injection
      • Control Test
      • Hangzhou, Zhejiang, China
        the Second Affiliated Hospital of Medical College of Zhejiang Un
      Apr 19, 2021

      Centralized Tumour Board and Secondary Intervention Rate in mCRC

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • +3 more
      • Virtual centralized multidisciplinary tumour board
      • (no location specified)
      Apr 15, 2021

      Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Germany (Cetuximab, FOLFIRI)

      Active, not recruiting
      • Adenocarcinoma of the Colon
      • Adenocarcinoma of the Rectum
      • Bochum, Germany
      • +3 more
      Oct 14, 2021

      Metastatic Colorectal Cancer Trial in France, Martinique (FOLFOX + panitumumab)

      Recruiting
      • Metastatic Colorectal Cancer
      • FOLFOX + panitumumab
      • Sainte Colombe, Lyon, France
      • +45 more
      Mar 23, 2022

      Hematological Anomalies in Children With Rasopathy

      Not yet recruiting
      • RAS Mutation
        • (no location specified)
        Aug 17, 2020

        MSS, RAS-mutant Colorectal Cancer Trial in Worldwide (binimetinib, nivolumab, ipilimumab)

        Completed
        Has Results
        • MSS
        • RAS-mutant Colorectal Cancer
        • Los Angeles, California
        • +49 more
        Dec 8, 2021

        Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

        Recruiting
        • Colorectal Cancer
        • Metastatic Colorectal Cancer
        • Birmingham, Alabama
        • +38 more
        Jan 25, 2023

        Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory

        Active, not recruiting
        • Metastatic Colon Carcinoma
        • +24 more
        • Laboratory Biomarker Analysis
        • +2 more
        • Corona, California
        • +7 more
        Oct 26, 2022

        Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)

        Completed
        • Infiltrating Urothelial Carcinoma
        • KRAS Gene Mutation
        • Bordeaux, France
        • +16 more
        Mar 4, 2021

        Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

        Not yet recruiting
        • Metastatic Colorectal Cancer
        • Shanghai, Shanghai, China
          Department of Colorectal Surgery Fudan University Shanghai Caner
        Nov 23, 2022

        Treatment Related Cancer Trial in Munich (Panitumumab, Irinotecan, Folinic acid)

        Not yet recruiting
        • Treatment Related Cancer
        • Munich, Germany
          Ludwigs Maximialians University
        Jul 24, 2019

        Advanced or Metastatic Solid Tumors Trial (Naporafinib, Trametinib)

        Not yet recruiting
        • Advanced or Metastatic Solid Tumors
        • (no location specified)
        Jun 21, 2023

        Colon Cancer Stage III Trial in Mansoura (k ras, Panitumumab)

        Completed
        • Colon Cancer Stage III
        • Mansoura, Ad Daqahliyah, Egypt
          Mansoura University Oncology Center
        Apr 8, 2020

        Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

        Not yet recruiting
        • Colorectal Cancer
        • BRAF V600E Mutation Positive
        • Encorafenib Oral Capsule + Cetuximab
        • (no location specified)
        Jan 30, 2023